Quantitative role of COMT in dopamine clearance in the prefrontal cortex of freely moving mice.
Catechol-O-methyltransferase (COMT) plays an active role in the metabolism of dopamine (DA) in the prefrontal cortex (PFC). Because of low levels of dopamine transporter (DAT), it is proposed that the majority of released DA is taken up by either norepinephrine transporter (NET) and subsequently metabolized by monoamine oxidize (MAO) or by uptake(2) (to glial cells and post-synaptic neurons) and metabolized by COMT. However, a comprehensive in vivo study of rating the mechanisms involved in DA clearance in the PFC has not been done. Here, we employ two types of microdialysis to study these pathways using DAT, NET and MAO blockers in conscious mice, with or without Comt gene disruption. In quantitative no-net-flux microdialysis, DA levels were increased by 60% in the PFC of COMT-knockout (ko) mice, but not in the striatum and nucleus accumbens. In conventional microdialysis studies, we showed that selective NET and MAO inhibition increased DA levels in the PFC of wild-type mice by two- to fourfold, an effect that was still doubled in COMT-ko mice. Inhibition of DAT had no effect on DA levels in either genotype. Therefore, we conclude that in the mouse, PFC COMT contributes about one half of the total DA clearance.
Käenmäki
Mikko
M
Division of Pharmacology and Toxicology, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland. mikko.kaenmaki@helsinki.fi
Tammimäki
Anne
A
Myöhänen
Timo
T
Pakarinen
Kaisa
K
Amberg
Carolina
C
Karayiorgou
Maria
M
Gogos
Joseph A
JA
Männistö
Pekka T
PT
D000818:Animals; D002394:Catechol O-Methyltransferase / Q000235:genetics / Q000502:physiology*; D003342:Corpus Striatum / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D050483:Dopamine Plasma Membrane Transport Proteins / Q000037:antagonists & inhibitors; D005260:Female; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D017551:Microdialysis; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009154:Mutation; D050484:Norepinephrine Plasma Membrane Transport Proteins / Q000037:antagonists & inhibitors / Q000378:metabolism; D009714:Nucleus Accumbens / Q000378:metabolism; D017397:Prefrontal Cortex / Q000187:drug effects / Q000378:metabolism*
D050483:Dopamine Plasma Membrane Transport Proteins; D008996:Monoamine Oxidase Inhibitors; D050484:Norepinephrine Plasma Membrane Transport Proteins; D002394:Catechol O-Methyltransferase; D004298:Dopamine